In Depth 1 Dec 2022
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy was a major milestone that has changed the lives of millions; the goal…
Immunocore
- Latest Posts
News and Trends 7 Jun 2017
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO 2017 meeting in Chicago. European biotech was in the spotlight during this year's edition of…
Best in Biotech 20 Dec 2021
The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European biotech is growing steadily and this year we welcome a…
Best in Biotech 28 Dec 2020
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at some of the top moments in the last 12 months. …
ADVERTISEMENT
Best in Biotech 17 Sep 2020
The Top 10 Biotech Companies Brewing at Oxford
Here are the top biotech companies in Oxford, a city with an old scientific tradition and an enormous output of biotech applications. Oxford is well known for its university, one…
News and Trends 4 Mar 2020
Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B
UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding…
News and Trends 20 Nov 2018
Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy
Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore's immunotherapy for treating solid tumors. In the agreement, Genentech, a…
Best in Biotech 20 Feb 2018
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our finances and budget for the year ahead. With money on…
Best in Biotech 27 Dec 2017
The Biggest Biotech News of 2017: What Happened This Year?
Still catching up on news? We've picked out the most exciting things that happened besides clinical results and finance. Here's the biggest biotech news of 2017. We've been recapping the…
News and Trends 12 Dec 2017
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100 available to patients with uveal melanoma before approval. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA)…
News and Trends 13 Nov 2017
World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of the best work being done by biotechs to fight resistance. An estimated 154 million prescriptions for antibiotics…
News and Trends 13 Nov 2017
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for its TCR immunotherapy IMCgp100 in patients suffering from metastatic uveal melanoma. Results are positive, but…
